Evidence map›Paper›PMID 34440574›Full record

ArticleLife (Basel, Switzerland)2021

Differential Mucosal Microbiome Profiles across Stages of Human Colorectal Cancer.

Mingqing Zhang, Yongming Lv, Shaobin Hou, Yanfei Liu, Yijia Wang, Xuehua Wan

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mingqing ZhangNankai University School of Medicine, Nankai University, Tianjin 300071, China.
Yongming LvTianjin Union Medical Center, Nankai University, Tianjin 300121, China.
Shaobin HouAdvanced Studies in Genomics, Proteomics and Bioinformatics, University of Hawaii, Honolulu, HI 96822, USA.
Yanfei LiuTianjin Union Medical Center, Nankai University, Tianjin 300121, China.
Yijia WangTianjin Union Medical Center, Nankai University, Tianjin 300121, China.
Xuehua WanTEDA Institute of Biological Sciences and Biotechnology, Nankai University, TEDA, Tianjin 300071, China.ORCID 0000-0002-6367-848X

Funding

the Fundamental Research Funds for the Central Universities, Nankai University 63191440the Natural Science Foundation of China 81972826Tianjin 131 Innovative Talent Training Project 2018
6 · The paper itself

Abstract

Emerging evidences link gut microbiota to colorectal cancer (CRC) initiation and development. However, the CRC stage- and spatial-specific bacterial taxa were less investigated, especially in a Chinese cohort, leading to our incomplete understanding of the functional roles of gut microbiota in promoting CRC progression and recurrence. Here, we report the composition and structure of gut microbiota across CRC stages I, II and III, by analyzing the gut mucosal microbiomes of 75 triplet-paired samples collected from on-tumor, adjacent-tumor and off-tumor sites and 26 healthy controls. We observed tumor-specific pattern of mucosal microbiome profiles as CRC progressed and identified ten bacterial taxa with high abundances (>1%) as potential biomarkers for tumor initiation and development.

Indexed as

16S rRNA sequencingcolorectal cancergut microbiota

Identifiers

PMID34440574
PMCPMC8401903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.